{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:06:20Z","timestamp":1791839180239,"version":"4.3.4"},"reference-count":145,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"am","delay-in-days":280,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.semcancer.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T12:04:16Z","timestamp":1685966656000},"page":"21-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Obesity and renal cell carcinoma: Biological mechanisms and perspectives"],"prefix":"10.1016","volume":"94","author":[{"given":"Neha","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"McQuade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Msaouel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2023.06.001_bib1","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2023.06.001_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 world health organization classification of tumours of the urinary system and male genital organs-part a: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clgc.2020.11.005","article-title":"Systemic therapies for the management of non-clear cell renal cell carcinoma: what works, what doesn't, and what the future holds","volume":"19","author":"Zoumpourlis","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib4","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1158\/2159-8290.CD-21-0211","article-title":"Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma","volume":"11","author":"Riscal","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2023.06.001_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209639120","article-title":"SMARCB1 regulates the hypoxic stress response in sickle cell trait","volume":"120","author":"Soeung","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2023.06.001_bib6","article-title":"Hypersensitivity to ferroptosis in chromophobe RCC is mediated by a glutathione metabolic dependency and cystine import via solute carrier family 7 member 11","volume":"119","author":"Zhang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2023.06.001_bib7","series-title":"The MD Anderson Manual of Medical Oncology","article-title":"Renal Cell Carcinoma","author":"Hahn","year":"2022"},{"key":"10.1016\/j.semcancer.2023.06.001_bib8","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.79.2523","article-title":"Genetic predisposition to renal cell carcinoma: implications for counseling, testing, screening, and management","author":"Shuch","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib9","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1158\/1078-0432.CCR-17-3296","article-title":"A model linking sickle cell hemoglobinopathies and SMARCB1 loss in renal medullary carcinoma","volume":"24","author":"Msaouel","year":"2018","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.semcancer.2023.06.001_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clgc.2018.09.005","article-title":"Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma","volume":"17","author":"Msaouel","year":"2019","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 Update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks","volume":"70","author":"Cumberbatch","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0013-9351(87)80200-1","article-title":"Asbestos and renal adenocarcinoma: a case-control study","volume":"42","author":"Maclure","year":"1987","journal-title":"Environ. Res"},{"key":"10.1016\/j.semcancer.2023.06.001_bib15","first-page":"672","article-title":"Petroleum-related employment and renal cell cancer","volume":"27","author":"McLaughlin","year":"1985","journal-title":"J. Occup. Med"},{"key":"10.1016\/j.semcancer.2023.06.001_bib16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2018.3060","article-title":"Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016","volume":"319","author":"Hales","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.semcancer.2023.06.001_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1749-6632.2012.06737.x","article-title":"Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue","volume":"1271","author":"Hursting","year":"2012","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.semcancer.2023.06.001_bib18","article-title":"Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: a review of the evidence using second-generation p-values","volume":"23","author":"Adashek","year":"2020","journal-title":"Cancer Treat. Res Commun."},{"key":"10.1016\/j.semcancer.2023.06.001_bib19","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1158\/0008-5472.CAN-22-0121","article-title":"Activating mTOR mutations are detrimental in nutrient-poor conditions","volume":"82","author":"Bielska","year":"2022","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2023.06.001_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4161\/adip.22880","article-title":"New insights into adipose tissue VEGF-A actions in the control of obesity and insulin resistance","volume":"2","author":"Elias","year":"2013","journal-title":"Adipocyte"},{"key":"10.1016\/j.semcancer.2023.06.001_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10456-022-09848-3","article-title":"Angiogenesis in adipose tissue and obesity","volume":"25","author":"Corvera","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.semcancer.2023.06.001_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI134813","article-title":"The 2019 Nobel Prize honors fundamental discoveries in hypoxia response","volume":"130","author":"Moslehi","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.semcancer.2023.06.001_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/KCA-210123","article-title":"First-Line Immuno-Oncology Combinations for Metastatic Clear Cell Renal Cell Carcinoma (mRCC): A Systematic Review of Phase III Clinical Trials","volume":"5","author":"Hahn","year":"2021","journal-title":"Kidney Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib24","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1158\/2159-8290.CD-20-1680","article-title":"The next decade of immune checkpoint therapy","volume":"11","author":"Sharma","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2023.06.001_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13668-019-00280-6","article-title":"The obesity paradox in cancer: epidemiologic insights and perspectives","volume":"8","author":"Lee","year":"2019","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.semcancer.2023.06.001_bib27","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ccell.2020.04.002","article-title":"Comprehensive molecular characterization identifies distinct genomic and immune hallmarks of renal medullary carcinoma","volume":"37","author":"Msaouel","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2023.06.001_bib28","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1158\/1078-0432.CCR-06-2510","article-title":"Pseudohypoxic pathways in renal cell carcinoma","volume":"13","author":"Bratslavsky","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.semcancer.2023.06.001_bib29","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1158\/0008-5472.CAN-20-0754","article-title":"Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma","volume":"80","author":"Xiao","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2023.06.001_bib30","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1200\/JCO.2017.77.5254","article-title":"HIF2 Inhibitor Joins the Kidney Cancer Armamentarium","volume":"36","author":"Kaelin","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2012.06.001","article-title":"The VHL\/HIF axis in clear cell renal carcinoma","volume":"23","author":"Shen","year":"2013","journal-title":"Semin Cancer Biol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib32","first-page":"8","article-title":"Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism","author":"Mylonis","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.semcancer.2023.06.001_bib33","article-title":"Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma","volume":"216","author":"Yuan","year":"2020","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.semcancer.2023.06.001_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: Still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2023.06.001_bib35","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.molcel.2021.08.031","article-title":"Moonlighting functions of metabolic enzymes and metabolites in cancer","volume":"81","author":"Pan","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcancer.2023.06.001_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00441-018-2801-6","article-title":"Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma","volume":"372","author":"Kluckova","year":"2018","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.semcancer.2023.06.001_bib37","first-page":"36","article-title":"Renal cell carcinoma in the era of precision medicine: from molecular pathology to tissue-based biomarkers","author":"Signoretti","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2019.06.015","article-title":"Familial kidney cancer: implications of new syndromes and molecular insights","volume":"76","author":"Carlo","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib39","first-page":"12","article-title":"Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization","author":"S\u00e1nchez-Heras","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2023.06.001_bib40","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/pbc.25592","article-title":"Renal medullary carcinoma and sickle cell trait: a systematic review","volume":"62","author":"Alvarez","year":"2015","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib41","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bju.13705","article-title":"Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study","volume":"120","author":"Shah","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.semcancer.2023.06.001_bib42","first-page":"13","article-title":"Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies","author":"Shapiro","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2023.06.001_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clgc.2020.11.005","article-title":"Systemic therapies for the management of non\u2013clear cell renal cell carcinoma: what works, what doesn\u2019t, and what the future holds","volume":"19","author":"Zoumpourlis","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib44","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2023.06.001_bib45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/cncr.30314","article-title":"Renal cancer subtypes: should we be lumping or splitting for therapeutic decision making?","volume":"123","author":"Haake","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.semdp.2015.02.004","article-title":"Distal nephron neoplasms","volume":"32","author":"Fleming","year":"2015","journal-title":"Semin Diagn. Pathol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib47","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0022-5347(01)66944-1","article-title":"Chromophobe cell renal carcinoma: clinicopathological features of 50 cases","volume":"154","author":"Crotty","year":"1995","journal-title":"J. Urol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07357907.2021.1999971","article-title":"Causal considerations can inform the interpretation of surprising associations in medical registries","volume":"40","author":"Carmona-Bayonas","year":"2022","journal-title":"Cancer Invest"},{"key":"10.1016\/j.semcancer.2023.06.001_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07357907.2022.2137914","article-title":"Risk model development and validation in clinical oncology: lessons learned","volume":"41","author":"Lyman","year":"2023","journal-title":"Cancer Invest"},{"key":"10.1016\/j.semcancer.2023.06.001_bib50","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.clgc.2020.08.003","article-title":"Causal diagram techniques for urologic oncology research","volume":"19","author":"Shapiro","year":"2021","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163923","article-title":"A causal framework for making individualized treatment decisions in oncology","volume":"14","author":"Msaouel","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.semcancer.2023.06.001_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","article-title":"Causal diagrams for epidemiologic research","volume":"10","author":"Greenland","year":"1999","journal-title":"Epidemiology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib53","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ijo.2017.99","article-title":"The \u2018obesity paradox\u2019 may not be a paradox at all","volume":"41","author":"Banack","year":"2017","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.semcancer.2023.06.001_bib54","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/oby.21239","article-title":"Smoking and reverse causation create an obesity paradox in cardiovascular disease","volume":"23","author":"Stokes","year":"2015","journal-title":"Obes. (Silver Spring)"},{"key":"10.1016\/j.semcancer.2023.06.001_bib55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc.2017.32","article-title":"Common pitfalls in preclinical cancer target validation","volume":"17","author":"Kaelin","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib56","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1038\/s41467-020-19478-2","article-title":"Collider bias undermines our understanding of COVID-19 disease risk and severity","volume":"11","author":"Griffith","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2023.06.001_bib57","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/EDE.0000000000001516","article-title":"Toward a Clearer Definition of Selection Bias When Estimating Causal Effects","volume":"33","author":"Lu","year":"2022","journal-title":"Epidemiology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib58","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10654-015-0069-7","article-title":"From bad to worse: collider stratification amplifies confounding bias in the \"obesity paradox\"","volume":"30","author":"Banack","year":"2015","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/EDE.0000000000000493","article-title":"Collider bias is only a partial explanation for the obesity paradox","volume":"27","author":"Sperrin","year":"2016","journal-title":"Epidemiology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/rssb.12348","article-title":"Making sense of sensitivity: extending omitted variable bias","volume":"82","author":"Cinelli","year":"2020","journal-title":"J. R. Stat. Soc. Ser. B: Stat. Methodol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib61","series-title":"Probabilistic and Causal Inference: The Works of Judea Pearl","first-page":"605","article-title":"The Causal Foundations of Applied Probability and Statistics","author":"Greenland","year":"2022"},{"key":"10.1016\/j.semcancer.2023.06.001_bib62","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/07357907.2021.1974030","article-title":"Impervious to randomness: confounding and selection biases in randomized clinical trials","volume":"39","author":"Msaouel","year":"2021","journal-title":"Cancer Invest"},{"key":"10.1016\/j.semcancer.2023.06.001_bib63","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/ije\/25.6.1107","article-title":"Basic methods for sensitivity analysis of biases","volume":"25","author":"Greenland","year":"1996","journal-title":"Int J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib64","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00001648-200009000-00010","article-title":"A sensitivity analysis to separate bias due to confounding from bias due to predicting misclassification by a variable that does both","volume":"11","author":"Lash","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib65","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.ede.0000134867.12896.23","article-title":"The value of risk-factor (\"black-box\") epidemiology","volume":"15","author":"Greenland","year":"2004","journal-title":"Epidemiology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib66","first-page":"550","article-title":"In defense of black box epidemiology","volume":"5","author":"Savitz","year":"1994","journal-title":"Epidemiology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib67","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/193229680800200623","article-title":"Body composition methods: comparisons and interpretation","volume":"2","author":"Duren","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1385\/ENDO:13:2:135","article-title":"Assessment and prevalence of obesity: application of new methods to a major problem","volume":"13","author":"Chumlea","year":"2000","journal-title":"Endocrine"},{"key":"10.1016\/j.semcancer.2023.06.001_bib69","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pst.331","article-title":"Consequences of dichotomization","volume":"8","author":"Fedorov","year":"2009","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.semcancer.2023.06.001_bib70","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","article-title":"The cost of dichotomising continuous variables","volume":"332","author":"Altman","year":"2006","journal-title":"Bmj"},{"key":"10.1016\/j.semcancer.2023.06.001_bib71","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/sim.2331","article-title":"Dichotomizing continuous predictors in multiple regression: a bad idea","volume":"25","author":"Royston","year":"2006","journal-title":"Stat. Med"},{"key":"10.1016\/j.semcancer.2023.06.001_bib72","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/oxfordjournals.aje.a116026","article-title":"Differential misclassification arising from nondifferential errors in exposure measurement","volume":"134","author":"Flegal","year":"1991","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2288-12-21","article-title":"Against quantiles: categorization of continuous variables in epidemiologic research, and its discontents","volume":"12","author":"Bennette","year":"2012","journal-title":"BMC Med Res Method."},{"key":"10.1016\/j.semcancer.2023.06.001_bib74","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-19425-7","author":"Harrell","year":"2015","journal-title":"Regres. Model. Strateg."},{"key":"10.1016\/j.semcancer.2023.06.001_bib75","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41409-019-0679-x","article-title":"Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians","volume":"55","author":"Gauthier","year":"2020","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.semcancer.2023.06.001_bib76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/oxfordjournals.aje.a009430","article-title":"Does body mass index adequately capture the relation of body composition and body size to health outcomes?","volume":"147","author":"Michels","year":"1998","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib77","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/aje\/kwp293","article-title":"Invited Commentary: causal diagrams and measurement bias","volume":"170","author":"Hern\u00e1n","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib78","first-page":"370","article-title":"Towards cancer-aware life-history modelling","author":"Kokko","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.semcancer.2023.06.001_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002118","article-title":"Association between adult height and risk of colorectal, lung, and prostate cancer: results from meta-analyses of prospective studies and mendelian randomization analyses","volume":"13","author":"Khankari","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.semcancer.2023.06.001_bib80","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5826\/dpc.0902a02","article-title":"Association between melanoma risk and height: a narrative review","volume":"9","author":"Vena","year":"2019","journal-title":"Dermatol. Pr. Concept"},{"key":"10.1016\/j.semcancer.2023.06.001_bib81","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/aje\/kwh344","article-title":"Relation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort Study","volume":"160","author":"van Dijk","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib82","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10654-020-00605-8","article-title":"Early life body size in relation to risk of renal cell carcinoma in adulthood: a Danish observational cohort study","volume":"35","author":"Jensen","year":"2020","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib83","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/jnci\/dji039","article-title":"Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer","volume":"97","author":"Michels","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2023.06.001_bib84","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2023.06.001_bib85","article-title":"The association between BMI and kidney cancer risk: An updated dose-response meta-analysis in accordance with PRISMA guideline","volume":"97","author":"Liu","year":"2018","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.semcancer.2023.06.001_bib86","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/aje\/kwm137","article-title":"Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States)","volume":"166","author":"Luo","year":"2007","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib87","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2022.04.032","article-title":"Obesity in Relation to Renal Cell Carcinoma Incidence and Survival in Three Prospective Studies","volume":"82","author":"Graff","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib88","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41416-019-0500-z","article-title":"Obesity, abdominal obesity and subsequent risk of kidney cancer: a cohort study of 23.3 million East Asians","volume":"121","author":"Nam","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib89","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/bju.12592","article-title":"Visceral fat accumulation is associated with different pathological subtypes of renal cell carcinoma (RCC): a multicentre study in China","volume":"114","author":"Wang","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.semcancer.2023.06.001_bib90","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body Fatness and Cancer--Viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2023.06.001_bib91","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/bjc.2013.37","article-title":"The association between physical activity and renal cancer: systematic review and meta-analysis","volume":"108","author":"Behrens","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib92","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM199503093321006","article-title":"Hypoxia of the renal medulla--its implications for disease","volume":"332","author":"Brezis","year":"1995","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2023.06.001_bib93","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semnephrol.2009.03.008","article-title":"The physiology of urinary concentration: an update","volume":"29","author":"Sands","year":"2009","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib94","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jama.1948.72890260003008a","article-title":"Sickle cell disease with severe hematuria simulating renal neoplasm","volume":"136","author":"Abel","year":"1948","journal-title":"J. Am. Med Assoc."},{"key":"10.1016\/j.semcancer.2023.06.001_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199501000-00001","article-title":"Renal medullary carcinoma. The seventh sickle cell nephropathy","volume":"19","author":"Davis","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib96","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3324\/haematol.2018.206060","article-title":"The carrier state for sickle cell disease is not completely harmless","volume":"104","author":"Xu","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2023.06.001_bib97","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1152\/japplphysiol.00338.2007a","article-title":"Counterpoint: Sickle cell trait should not be considered asymptomatic and as a benign condition during physical activity","volume":"103","author":"Connes","year":"2007","journal-title":"J. Appl. Physiol. (1985)"},{"key":"10.1016\/j.semcancer.2023.06.001_bib98","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.urology.2006.05.024","article-title":"Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma","volume":"68","author":"Parker","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib99","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/j.1464-410X.2007.07375.x","article-title":"The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy","volume":"101","author":"Haferkamp","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.semcancer.2023.06.001_bib100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.urology.2003.08.009","article-title":"Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors","volume":"63","author":"Kamat","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib101","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0022-5347(05)00054-6","article-title":"Impact of body mass index on survival of patients with surgically treated renal cell carcinoma","volume":"175","author":"Donat","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib102","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.urology.2007.03.034","article-title":"Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma","volume":"70","author":"Awakura","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib103","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jso.20139","article-title":"Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients","volume":"88","author":"Schips","year":"2004","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib104","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jnci\/djt310","article-title":"An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma","volume":"105","author":"Hakimi","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.semcancer.2023.06.001_bib105","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/jcsm.12167","article-title":"Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016","volume":"7","author":"von Haehling","year":"2016","journal-title":"J. Cachex-.-. Sarcopenia Muscle"},{"key":"10.1016\/j.semcancer.2023.06.001_bib106","doi-asserted-by":"crossref","first-page":"E675","DOI":"10.5489\/cuaj.1979","article-title":"Association between visceral and subcutaneous adiposity and clinicopathological outcomes in non-metastatic clear cell renal cell carcinoma","volume":"8","author":"Mano","year":"2014","journal-title":"Can. Urol. Assoc. J."},{"key":"10.1016\/j.semcancer.2023.06.001_bib107","doi-asserted-by":"crossref","first-page":"16718","DOI":"10.1038\/s41598-022-20877-2","article-title":"Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma","volume":"12","author":"Maurits","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2023.06.001_bib108","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1200\/JCO.2016.66.7311","article-title":"Body mass index and metastatic renal cell carcinoma: clinical and biological correlations","volume":"34","author":"Albiges","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib109","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(19)30797-1","article-title":"Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study","volume":"21","author":"Sanchez","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamaoncol.2021.0019","article-title":"Assessment of immune checkpoint inhibitors and genomic alterations by body mass index in advanced renal cell carcinoma","volume":"7","author":"Lalani","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2023.03.006","article-title":"Clinico-pathological features influencing the prognostic role of Body Mass Index in patients with advanced Renal Cell Carcinoma treated by immuno-oncology combinations (ARON-1)","author":"Santoni","year":"2023","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib112","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.euo.2021.09.003","article-title":"Adjuvant systemic therapies for patients with renal cell carcinoma: choosing treatment based on patient-level characteristics","volume":"5","author":"Msaouel","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib113","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/07357907.2021.2020281","article-title":"Fooled by Randomness. The Misleading Effect of Treatment Crossover in Randomized Trials of Therapies with Marginal Treatment Benefit","volume":"40","author":"Valent\u00ed","year":"2022","journal-title":"Cancer Invest"},{"key":"10.1016\/j.semcancer.2023.06.001_bib114","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.clnu.2021.11.012","article-title":"Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study","volume":"41","author":"Maurits","year":"2022","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.semcancer.2023.06.001_bib115","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1158\/1078-0432.CCR-22-1389","article-title":"Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Blockade","volume":"28","author":"Ged","year":"2022","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.semcancer.2023.06.001_bib116","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.kint.2021.03.011","article-title":"From kidney injury to kidney cancer","volume":"100","author":"Peired","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.semcancer.2023.06.001_bib117","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.soard.2014.08.012","article-title":"Obesity and cancer: at the crossroads of cellular metabolism and proliferation","volume":"10","author":"O'Rourke","year":"2014","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.semcancer.2023.06.001_bib118","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13813450801954303","article-title":"Obesity and cancer: pathophysiological and biological mechanisms","volume":"114","author":"Renehan","year":"2008","journal-title":"Arch. Physiol. Biochem"},{"key":"10.1016\/j.semcancer.2023.06.001_bib119","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib120","first-page":"20","article-title":"The role of obesity in renal cell carcinoma patients: clinical-pathological implications","author":"Aurilio","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2023.06.001_bib121","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.3892\/ijmm.2016.2776","article-title":"Mechanisms through which diabetes mellitus influences renal cell carcinoma development and treatment: A review of the literature","volume":"38","author":"Labochka","year":"2016","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.semcancer.2023.06.001_bib122","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/gast.2001.25490","article-title":"Leptin is a growth factor for colonic epithelial cells","volume":"121","author":"Hardwick","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcancer.2023.06.001_bib123","doi-asserted-by":"crossref","first-page":"26320","DOI":"10.1074\/jbc.M601991200","article-title":"Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2)","volume":"281","author":"Gonzalez","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2023.06.001_bib124","first-page":"11","article-title":"Leptin Is Associated with Poor Clinical Outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression","author":"Fan","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.semcancer.2023.06.001_bib125","doi-asserted-by":"crossref","first-page":"17210","DOI":"10.18632\/oncotarget.24966","article-title":"Leptin signaling axis specifically associates with clinical prognosis and is multifunctional in regulating cancer progression","volume":"9","author":"Lin","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2023.06.001_bib126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nat. Med"},{"key":"10.1016\/j.semcancer.2023.06.001_bib127","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41575-018-0053-2","article-title":"Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms","volume":"15","author":"Ulrich","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib128","first-page":"20","article-title":"Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease","author":"Parida","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2023.06.001_bib129","article-title":"Reassessing Human Adipose Tissue","volume":"386","author":"Buti","year":"2022","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.semcancer.2023.06.001_bib130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/carcin\/bgg006","article-title":"Expression of cyclooxygenase-2 parallels expression of interleukin-1beta, interleukin-6 and NF-kappaB in human colorectal cancer","volume":"24","author":"Maih\u00f6fner","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.semcancer.2023.06.001_bib131","doi-asserted-by":"crossref","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2023.06.001_bib132","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1541-7786.MCR-13-0238","article-title":"Interleukin-6 and oncostatin-M synergize with the PI3K\/AKT pathway to promote aggressive prostate malignancy in mouse and human tissues","volume":"11","author":"Smith","year":"2013","journal-title":"Mol. Cancer Res"},{"key":"10.1016\/j.semcancer.2023.06.001_bib133","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cmet.2019.11.019","article-title":"Glutamine links obesity to inflammation in human white adipose tissue","volume":"31","author":"Petrus","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2023.06.001_bib134","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","article-title":"Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity","volume":"183","author":"Ringel","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2023.06.001_bib135","first-page":"358","article-title":"Twist2 and CD24 expression alters renal microenvironment in obesity associated kidney cancer","volume":"22","author":"Yang","year":"2018","journal-title":"Eur. Rev. Med Pharm. Sci."},{"key":"10.1016\/j.semcancer.2023.06.001_bib136","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.semcancer.2023.06.001_bib137","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2023.06.001_bib138","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","article-title":"We need to talk about the Warburg effect","volume":"2","author":"DeBerardinis","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.semcancer.2023.06.001_bib139","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.1158\/0008-5472.CAN-05-3197","article-title":"Mechanism of apoptosis induced by the inhibition of fatty acid synthase in breast cancer cells","volume":"66","author":"Bandyopadhyay","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2023.06.001_bib140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1073\/pnas.1808834116","article-title":"Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer","volume":"116","author":"Zadra","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.semcancer.2023.06.001_bib141","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2023.06.001_bib142","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000527090","article-title":"Perinephric toxic fat: impact on surgical complexity, perioperative outcome, and surgical approach in partial nephrectomy","volume":"107","author":"Walach","year":"2023","journal-title":"Urol. Int"},{"key":"10.1016\/j.semcancer.2023.06.001_bib143","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade","volume":"25","author":"Wang","year":"2019","journal-title":"Nat. Med"},{"key":"10.1016\/j.semcancer.2023.06.001_bib144","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2023.06.001_bib145","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/1078-0432.CCR-22-2661","article-title":"Obesity is associated with altered tumor metabolism in metastatic melanoma","volume":"29","author":"Hahn","year":"2023","journal-title":"Clin. Cancer Res"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X23000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X23000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:06:09Z","timestamp":1760918769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X23000901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":145,"alternative-id":["S1044579X23000901"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2023.06.001","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity and renal cell carcinoma: Biological mechanisms and perspectives","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}